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Abstract
This work proposes to analyze the capacity of several ECG features of
Lead I to discriminate 28 pairs of study groups, combining 7 patholog-
ical groups and 1 control group, presented in the PTB Diagnostic ECG
Database. For each pair, it was achieved an accuracy between 66.7% and
96.9% using feature selection algorithm and SVM classifiers.
1 Introduction
The electrocardiogram (ECG) is the recording of the rhythmic alterations
of the heart electrical activity and represents the cardiac cycle [2]. A typi-
cal ECG is usually recorded by means of a 12-lead system (I, II, III, aVR,
aVL, aVF, V1, V2, V3, V4, V5, V6). The amplitude and direction of the
current flow in the heart are detected by the electrodes, resulting in differ-
ent ECG signals according to the leads axis. An ECG signal of a healthy
subject is cyclically formed by a P wave, a QRS complex and a T wave.
Any minor change in the normal pattern of an ECG signal can be inter-
preted as malfunction of the heart [9]. Thus, autonomous and accurate
discrimination of cardiac pathologies through ECG is an important tool
to assist in the diagnosis of these diseases, especially considering that the
detection of cardiac disorder is an exhausting task for cardiologists. Dur-
ing the last years, several works have proposed methods to detect ECG
features (morphological or not) and then to diagnose cardiac pathologies.
The great majority of these methods aimed to discriminate Myocardial In-
farction (MI) from healthy controls, which can be explained by the greater
number of ECG records from patients diagnosed with this disease in the
public databases, mainly in the PTB Diagnostic ECG Database. Few
works tried to discriminate Dysrhythmia or Cardiomyopathy from healthy
controls. However, all works have the common goal of discriminating be-
tween 2 study groups, one pathological group and one control group, even
when ECG records from patients diagnosed with several pathologies are
available in the databases. This work proposes to analyze the capacity
of several ECG parameters from Lead I to discriminate 28 pairs of study
groups, combining 7 pathological groups and 1 control group.
2 Methods
2.1 ECG Database
This work used the PTB Diagnostic ECG Database available in [4, 5]. The
database contains 549 ECG records from 268 subjects, including healthy
subjects (52 subjects) and patients diagnosed with 7 pathologies, namely
Cardiomyopathy(18 subjects), bundle branch block (15 subjects), valvu-
lar heart disease (6 subjects), myocarditis (4 subjects), MI (148 subjects),
myocardial hypertrophy (7 subjects) and Dysrhythmia (14 subjects). Each
ECG record contains all the 12-lead system signals with a sampling rate
of 1000 Hz, but only Lead I signals were used on this work due to its
simplicity in acquisition. The ECG signals had their DC levels removed
and their amplitudes were normalized between −1 and 1.
2.2 Peaks detection
The proposed method detect the R, S, Q, P and T peaks of the ECG signal,
in that order, as follows:
• R peak: A Discrete Wavelet Transform (DWT) translation analy-
sis, using the wavelet symlet 4, is applied in order to calculate the
cross-correlation between the signal and the DWT. The R peaks are
the maximum of each correlation over the channel. To find all R
peaks in the ECG a 70% signal amplitude threshold of the DWT’s
maximum was used to make sure that just the most prominent cor-
relation peak in each heart cycle is detected.
• S peak: The S peak was identified as being the first negative mini-
mum wave after the R peak [8].
• Q peak: Contrary to S peak, the Q peak was identified as being the
negative minimum wave right before a R peak [8].
• T peak: For this peak detection all the other previously identified
waves are used as references. The signal between the Q and S
waves was set to zero, as well as all the negative signal amplitudes.
The remaining signal samples were amplified by fifth rooting the
signal. Finally to find T peak, the ECG signal was set to zero
in each cardiac cycle (CC) before the first CC1 S peak is detected
and after CC2 S peak is detected. After it the last 45% of the signal
between CC1 and CC2 was also set to 0 and T wave is estimated
as the maximum of the remaining signal (Figure 1).
Figure 1: T peak detection.
• P peak: For the P wave detection, the signal was amplified square
rooting it. Thus, all the signal between the Q peak and T peak
was set to -1. The signal between this peaks was not set to zero
because there is a chance of the P peak having a negative value, in
some cases. After it, the 55% of the signal between CC1 and CC2
was also set to -1. The P peak is estimated the maximum of the
resulting signal.
2.3 ECG Features Analyzed
After detecting the peaks of the P, Q, R, S and T waves, through Wavelet
Transform correlation, which are hereinafter called P, Q, R, S and T peaks,
of each cardiac cycle, several features of each Lead I ECG signal are cal-
culated in order to analyze their discrimination capacities. The analyzed
features are: energy between Q and S peaks, power between Q and S
peaks, energy of Wavelet Transform (WT) between Q and S peaks, detail
(det) and approximation (app) levels using symlet 4 and symlet 8 waves,
time between peaks, peaks amplitude (Amp.) and amplitude difference (a
Amp. diff.) between peaks. The features are summarized in the Table 1.
2.4 Classification
Leave-one-out and 5-fold cross validations were used for training and test-
ing the Support Vector Machines (SVM) models with Gaussian, linear
and polynomial kernel functions plus a cost of 10. The classification were
performed for 28 pairs of the study groups between 7 pathological groups
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Table 1: List of analyzed features and their indexes.
Index Feature Index Feature Index Feature
1 Energy Q-S 14 Time P-R 27 Amp. T
2 Power Q-S 15 Time P-S 28 Amp. diff. P-Q
3 WT ‘sym4’ app. level 4 energy 16 Time P-T 29 Amp. diff. P-R
4 WT ‘sym4’ det. level 1 energy 17 Time Q-R 30 Amp. diff. P-S
5 WT ‘sym4’ det. level 2 energy 18 Time Q-S 31 Amp. diff. P-T
6 WT ‘sym4’ det. level 3 energy 19 Time Q-T 32 Amp. diff. Q-R
7 WT ‘sym4’ det. level 4 energy 20 Time R-S 33 Amp. diff. Q-S
8 WT ‘sym8’ app. level 4 energy 21 Time R-T 34 Amp. diff. Q-T
9 WT ‘sym8’ det. level 1 energy 22 Time S-T 35 Amp. diff. R-S
10 WT ‘sym8’ det. level 2 energy 23 Amp. P 36 Amp. diff. R-T
11 WT ‘sym8’ det. level 3 energy 24 Amp. Q 37 Amp. diff. S-T
12 WT ‘sym8’ det. level 4 energy 25 Amp. R
13 Time P-Q 26 Amp. S
and 1 control group. Finally, a Genetic algorithms with entropy criterion
were applied for feature selection from matrices with 37 features per X
subjects (X is the number of the patients involved in each classification
pair). The 37 features resulted from the mean features values extracted
from each ECG cycle per subject (I lead), as described in Table 1.
3 Results and Discussion
As previously said, in subsection 2.4, the classifications were performed
for 28 pairs of the study groups combining 7 pathological groups and
1 control group. The results shown in Figure 2 are the best accuracies
achieved from the six trained/tested SVM with Leave-one-out and 5-fold
cross validations using gaussian, linear and polynomial functions as ker-
nels and a cost of 10. As can be observed from Figure 2, the maximum
accuracy classification was achieved for the pairs Valvular heart disease
vs. MI and Myocarditis vs. MI with 96.9% and the Myocarditis vs. My-
ocardial hypertrophy provided the lowest accuracy classification (66.7%).
Moreover, it can be noticed that the best features were capable of discrim-
inating Healthy controls from any other heart disease with an accuracy
higher than 91% for the exception of Bundle branch block and MI where
the reached accuracies were 85.9% and 77.8%, respectively. For the pairs
Healthy controls vs. Cardiomyopathy and Healthy controls vs. Dysrhyth-
mia the classifiers achieved an accuracy of 93.7% and 92.3%. The distin-
guish accuracies between Healthy controls against MI, Dysrhythmia and
Cardiomyopathy are slightly under the results of those in the state-of-art
(Teble 2) and can be explained by the fact that the methods available in
the literature use multiple leads and, as previously mentioned, not just one
lead as this work.
Table 2: List of works found in the literature.
References Pathologie Numberof Leads Method and Classification Accuracies
[1] MI 12 leads
ST segment elevation and threshold
classification
92.5%
[7] MI 3 lead
Q peak depth and ST segment elevation.
Classification by a simple adaptive threshold
90.56%
[6] Dysrhythmia 12 leads
Template construction from CWT features
using a morphological consistency classifier
93.0%
[3] Cardiomyopathy 12 leads
PR, RR, QT and QRS intervals analysis.
Classification through BPNN
95.2%
Therefore, using only Lead I analysis, the SVM classifier was able to
achieve an accuracy between 66.7% and 96.9% for the 28 pairs of study
groups showing Lead I has good capacity for heart pathologies discrimi-
nation, however, the low number of records for some pathologies should
be taken in consideration.
4 Conclusion
Autonomous and accurate discrimination of cardiac pathologies through
ECG is an important tool to assist in the diagnosis of heart diseases. The
works found in the literature have the common goal of discriminating be-
tween 2 study groups, one pathological and one control, even when ECG
records from patients diagnosed with several pathologies are available in
the databases. This work have analyzed the capacity of several ECG fea-
tures to discriminate 28 pairs of study groups, combining 7 pathologi-
cal groups and 1 control group, presented in the PTB Diagnostic ECG
Database. Using only Lead I, the SVM classifier was able to achieve
an accuracy between 66.7% and 96.9% for the 28 pairs of study groups.
These results become even more relevant considering that only 3 of these
Figure 2: Pathologies discrimination accuracies.
pairs are commonly analyzed in the literature: MI, Dysrhythmia and Car-
diomyopathy. This study also proves Lead I has good capacity for heart
pathologies discrimination, however the low number of records for some
pathologies should be taken in consideration.
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